Acute Transfusion-Associated Lung Injury
https://doi.org/10.15360/1813-9779-2009-2-70
Abstract
The material of this publication has been prepared, by reviewing the data available in the Russian and foreign literatures on acute transfusion-associated lung injury. The paper considers the history of its study and the state-of-the-art. The epidemiology, etiology, pathogenesis, and pathomorphology of this complication are discussed. Particular emphasis is laid on the diagnosis of acute transfusion-associated lung injury, on the current criteria for verification of its diagnosis, and on the principles of a differentially diagnostic search. The clinical picture and treatment of this pathology are considered. The conclusion of the review gives the recommendations made by Russian and foreign experts to prevent acute transfusion-associated lung injury. Key words: acute transfusion-associated lung injury.
References
1. Жибурт Е. Б, Баранова О. В., Рейзман П. В., Кузьмин Н. С.http://www.transfusion.ru2.Barnard R. D.Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. NY State J. Med. 1951; 51: 2399—2402.3.Looney M. R., Gropper M. A., Matthay M. A.Transfusion-related acute lung injury: a review. Chest 2004; 126 (1): 249—258.4.Silliman C. C., Ambruso D. R., Boshkov L. K.Transfusion-related acute lung injury. Blood 2005; 105 (6): 2266—2273.5.Popovsky M. A., Moore S. B.Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25 (6): 573—577.6.Goldman M., Webert K. E., Arnold D. M. et al.Proceedings of a consensus conference: towards an understanding of TRALI. Transfus. Med. Rev. 2005; 19 (1): 2—31.7.Mintz P. D., Lipton K. S.Transfusion-related acute lung injury Association bulletin 2005;http://www.aabb.org8.Popovsky M. A., Chaplin H. C., Moore S. B.Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992; 32 (6): 589—592.9.Clarke G., Podlosky L., Petrie L., Boshkov L.Severe respiratory reactions to random donor platelets: an incidence and nested case-control study. Blood 1994; 84 (Suppl 1): 465a (abstract).10.Webert K. E., Blajchman M. A.Transfusion-related acute lung injury. Transfus. Med. Rev. 2003; 17 (4): 252—262.11.Rana R., Fernandez-Perez E., Khan S. et al.Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46 (9): 1478—1483.12.Silliman C.C., Boshkov L.K., Mehdizadehkashi Z. et al.Transfusion-related acute lung injury: epidemiology and a prospective analysis of etio-logic factors. Blood 2003; 101 (2): 454—462.13.Lee J. H.Transfusion-related fatalities. Reports to US FDA: 1990-1998. ABC Newslett. 1999.14.Popovsky M. A., Davenport R. D.Transfusion-related acute lung injury: femme fatale? Transfusion 2001; 41 (3): 312—331.15.Holness L., Callaghan E., Knippen M. et al.Transfusion-related acute lung injury: an update. Transfusion 2001; 41 (3): 9—18.16.Nordhagen R., Conradi M., Dromtorp S. M.Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox. Sang. 1986; 51 (2): 102—107.17.van Buren N. L., Stroncek D. F., Clay M. E. et al.Transfusion-related acute lung injury caused by an NB2 granulocytespecific antibody in a patient with thrombotic thrombocytopenic purpura. Tranfusion 1990; 30 (1): 42—45.18.Popovsky M. A., Haley N. R.Further characterization of transfusion-related acute lung injury: demographics, clinical and laboratory features and morbidity. Immunohematology 2000; 16 (4): 157—159.19.Payne R.The development and persistence of leukoagglutinins in parous women. Blood 1962; 19: 411—424.20.Densmore T. L., Goodnough L. T., Ali S. et al.Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999; 39 (1): 103—106.21.CampbellD. A. Jr., Swartz R. D., WaskerwitzJ. A. et al.Leukagglutination with interstitial pulmonary edema. A complication of donor-specific transfusion. Transplantation 1982; 34 (5): 300—301.22.Goeken N. E., Schulak J. A., Nghiem D. D. et al.Transfusion reactions in donor-specific blood transfusion patients resulting from transfused maternal antibody. Transplantation 1984; 38 (3): 306—307.23.Silliman C. C., Thurman G. W., Ambruso D. R. et al.Stored blood components contain agents that prime the neutrophil NAPDH oxidase through the platelet-activating-factor receptor. Vox. Sang. 1992; 63 (2): 133—136.24.Kopko P. M., Popovsky M. A., MacKenzie M. R. et al.HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41 (10): 1244—1248.25.Khan S. Y., Kelher M. R., Heal J. M. et al.Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108 (7): 2455—2462.26.Stroncek D. F.Hot on the trail of TRALI. Blood 2006; 108 (7): 2136—2137.27.Ory P. A., Goldstein I. M., Kwoh E. E., Clarkson S. B.Characterization of polymorphic forms of Fc receptor III on human neutrophils. J. Clin. Invest. 1989; 83 (5): 1676—1681.28.Bian H., Reed E. F.Alloantibody-mediated class I signal transduction in endothelial cells and smooths muscle cells: enhancement by IFN-gamma and TNF-alpha. J. Immunol. 1999; 163 (2): 1010—1018.29.Bussolino F., Camussi G., Aglietta M. et al.Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J. Immunol. 1987; 139 (7): 2439—2446.30.Biffl W. L., Moore E. E., Moore F. A. et al.Interleukin-6 stimulates neu-trophil production of platelet-activating factor. J. Leukoc. Biol. 1996; 59 (4): 569—574.31.Kleinman S., Caulfield T., Chan P. et al.Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44 (12): 1774—1789.32.Toy P., Popovsky M., Abraham E. et al.Transfusion-related acute lung injury: Definition and review. Crit. Care. Med. 2005; 33 (4): 721—726.33.Wallis J. P.Transfusion-related acute lung injury (TRALI) — under-diagnosed and under-reported. Br. J. Anaesth. 2003; 90(5): 573—575.34.Карпун Н. А., Мороз В. В., Руденко М. И. и соавт.Операционная нормоволемическая гемодилюция при хирургическом лечении ше-мической болезни сердца. Вестн. интенс. терапии 1999; 4: 11—19.35.Еременко А. А., Левиков Д. И., Зорин Д. Е. и соавт.Применение рекрутирующего маневра при лечении дыхательной недостаточности у кардиохирургических больных. Анестезиология и реаниматология 2006; 5: 37—42.36.Еременко А. А., Михайлов Ю. М., Кукаева Е. А.Кислородно-транспортная функция крови при уменьшении концентрации гемоглобина у больных после операций на открытом сердце. Анестезиология и реаниматология 1984; 4: 33-36.37.Milot J., Perron J., Lacasse Y.Incidence and predictors of ARDS after cardiac surgery. Chest 2001; 119 (3): 884—888.38.Michalopoulos A., Prapas S., Falagas M. E.The incidence of adult respiratory distress syndrome in patients undergoing of-pump coronary artery bypass grafting surgery. Eur. J. Anaesthesiol. 2006; 23 (1): 80.39.Fowler A. A., Hamman R. F., Good J. T. et al.Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 1983; 98 (5): 593—597.40.Власенко А. В, Закс И. О., Мороз В. В.Прошлое и будущее определения понятий острого повреждения лёгких и РДСВ и их лечения (обзор зарубежной литературы).http://www.reanimatolog.ru41.Kalkat M. S., Dandekar U., Jegannath V., Levine A.Transfusion-related acute lung injury in cardiac surgery. Asian Cardiovasc. Thorac. Ann. 2006; 14 (3): 65—67.42.БунятянА. А., ТрековаН. А.(ред.) Руководство по кардиоанестези-ологии. М.: Медицинское информационное агентство; 2005.43.Рябов Г. А.Синдромы критических состояний. М.: Медицина; 1994.44.Малышев В. Д., Андрюхин И. М., Бакушин B. C. и соавт.Гемогидродина-мический мониторинг при интенсивном лечении больных с тяжелым течением перитонита. Анестезиология и реаниматология 1997; 3: 68—71.45.Гельфанд Б. Р., Проценко Д. Н., Игнатенко О. В. и соавт.Острое повреждение легких вследствие трансфузии препаратов крови. Вестн. службы крови России 2007; 2: 38—42.46.Palfi M., Berg S., ErnerudhJ., Berlin G.A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001; 41 (3): 317—322.47.Kopko P. M., Marshall C. S., MacKenzie M. R. et al.Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287 (15): 1968—1971.48.Fontaine M. J., MaloneJ., Mullins F. M., Grumet F. C.Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI? Ann. Clin. Lab. Sci. 2006; 36 (1): 53—58.49.Goodnough L. T.What is transfusion medicine specialist? Transfusion 1999; 39 (9): 1031 — 1033.50.McCullough J.Research in transfusion medicine. Transfusion 2000; 40 (9): 1033—1035.51.Popovsky M. A.Transfusion and lung injury. Transfus. Clin. Biol. 2001; 8 (3): 272—277.52.РудновB. A., ЗубаревА. С., БазаровА. С. исоавт.Современная практика инфузионо-трансфузионной терапии в ОРИТ России. Вестн. службы крови России 2006; 2: 11—19.53.Жибурт Е. Б., Шестаков Е. А.Доказательная трансфузиология. Часть 1. О правилах назначения компонентов крови. Здравоохранение 2007; 11: 31—37.54. Неговский В. А., Мороз В. В.Актуальные вопросы реаниматологии. Анестезиология и реаниматология 1999; 1: 6—9.
2. Barnard R. D.Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. NY State J. Med. 1951; 51: 2399—240
3. Looney M. R., Gropper M. A., Matthay M. A.Transfusion-related acute lung injury: a review. Chest 2004; 126 (1): 249—258.
4. Silliman C. C., Ambruso D. R., Boshkov L. K.Transfusion-related acute lung injury. Blood 2005; 105 (6): 2266—2273.
5. Popovsky M. A., Moore S. B.Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25 (6): 573—577.
6. Goldman M., Webert K. E., Arnold D. M. et al.Proceedings of a consensus conference: towards an understanding of TRALI. Transfus. Med. Rev. 2005; 19 (1): 2—31.
7. Mintz P. D., Lipton K. S.Transfusion-related acute lung injury Association bulletin 2005;http://www.aabb.org
8. Popovsky M. A., Chaplin H. C., Moore S. B.Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992; 32 (6): 589—592.
9. Clarke G., Podlosky L., Petrie L., Boshkov L.Severe respiratory reactions to random donor platelets: an incidence and nested case-control study. Blood 1994; 84 (Suppl 1): 465a (abstract).
10. Webert K. E., Blajchman M. A.Transfusion-related acute lung injury. Transfus. Med. Rev. 2003; 17 (4): 252—262.
11. Rana R., Fernandez-Perez E., Khan S. et al.Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46 (9): 1478—1483.
12. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z. et al.Transfusion-related acute lung injury: epidemiology and a prospective analysis of etio-logic factors. Blood 2003; 101 (2): 454—462.
13. Lee J. H.Transfusion-related fatalities. Reports to US FDA: 1990-1998. ABC Newslett. 1999.
14. Popovsky M. A., Davenport R. D.Transfusion-related acute lung injury: femme fatale? Transfusion 2001; 41 (3): 312—331.
15. Holness L., Callaghan E., Knippen M. et al.Transfusion-related acute lung injury: an update. Transfusion 2001; 41 (3): 9—18.
16. Nordhagen R., Conradi M., Dromtorp S. M.Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox. Sang. 1986; 51 (2): 102—107.
17. van Buren N. L., Stroncek D. F., Clay M. E. et al.Transfusion-related acute lung injury caused by an NB2 granulocytespecific antibody in a patient with thrombotic thrombocytopenic purpura. Tranfusion 1990; 30 (1): 42—45.
18. Popovsky M. A., Haley N. R.Further characterization of transfusion-related acute lung injury: demographics, clinical and laboratory features and morbidity. Immunohematology 2000; 16 (4): 157—159.
19. Payne R.The development and persistence of leukoagglutinins in parous women. Blood 1962; 19: 411—424.
20. Densmore T. L., Goodnough L. T., Ali S. et al.Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999; 39 (1): 103—106.
21. CampbellD. A. Jr., Swartz R. D., WaskerwitzJ. A. et al.Leukagglutination with interstitial pulmonary edema. A complication of donor-specific transfusion. Transplantation 1982; 34 (5): 300—301.
22. Goeken N. E., Schulak J. A., Nghiem D. D. et al.Transfusion reactions in donor-specific blood transfusion patients resulting from transfused maternal antibody. Transplantation 1984; 38 (3): 306—307.
23. Silliman C. C., Thurman G. W., Ambruso D. R. et al.Stored blood components contain agents that prime the neutrophil NAPDH oxidase through the platelet-activating-factor receptor. Vox. Sang. 1992; 63 (2): 133—136.
24. Kopko P. M., Popovsky M. A., MacKenzie M. R. et al.HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41 (10): 1244—1248.
25. Khan S. Y., Kelher M. R., Heal J. M. et al.Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108 (7): 2455—2462.
26. Stroncek D. F.Hot on the trail of TRALI. Blood 2006; 108 (7): 2136—2137.
27. Ory P. A., Goldstein I. M., Kwoh E. E., Clarkson S. B.Characterization of polymorphic forms of Fc receptor III on human neutrophils. J. Clin. Invest. 1989; 83 (5): 1676—1681.
28. Bian H., Reed E. F.Alloantibody-mediated class I signal transduction in endothelial cells and smooths muscle cells: enhancement by IFN-gamma and TNF-alpha. J. Immunol. 1999; 163 (2): 1010—1018.
29. Bussolino F., Camussi G., Aglietta M. et al.Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J. Immunol. 1987; 139 (7): 2439—2446.
30. Biffl W. L., Moore E. E., Moore F. A. et al.Interleukin-6 stimulates neu-trophil production of platelet-activating factor. J. Leukoc. Biol. 1996; 59 (4): 569—574.
31. Kleinman S., Caulfield T., Chan P. et al.Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44 (12): 1774—1789.
32. Toy P., Popovsky M., Abraham E. et al.Transfusion-related acute lung injury: Definition and review. Crit. Care. Med. 2005; 33 (4): 721—726.
33. Wallis J. P.Transfusion-related acute lung injury (TRALI) — under-diagnosed and under-reported. Br. J. Anaesth. 2003; 90(5): 573—575.
34. Карпун Н. А., Мороз В. В., Руденко М. И. и соавт.Операционная нормоволемическая гемодилюция при хирургическом лечении ше-мической болезни сердца. Вестн. интенс. терапии 1999; 4: 11—19.
35. Еременко А. А., Левиков Д. И., Зорин Д. Е. и соавт.Применение рекрутирующего маневра при лечении дыхательной недостаточности у кардиохирургических больных. Анестезиология и реаниматология 2006; 5: 37—42.
36. Еременко А. А., Михайлов Ю. М., Кукаева Е. А.Кислородно-транспортная функция крови при уменьшении концентрации гемоглобина у больных после операций на открытом сердце. Анестезиология и реаниматология 1984; 4: 33-
37. Milot J., Perron J., Lacasse Y.Incidence and predictors of ARDS after cardiac surgery. Chest 2001; 119 (3): 884—888.
38. Michalopoulos A., Prapas S., Falagas M. E.The incidence of adult respiratory distress syndrome in patients undergoing of-pump coronary artery bypass grafting surgery. Eur. J. Anaesthesiol. 2006; 23 (1): 80.
39. Fowler A. A., Hamman R. F., Good J. T. et al.Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 1983; 98 (5): 593—597.
40. Власенко А. В, Закс И. О., Мороз В. В.Прошлое и будущее определения понятий острого повреждения лёгких и РДСВ и их лечения (обзор зарубежной литературы).http://www.reanimatolog.ru
41. Kalkat M. S., Dandekar U., Jegannath V., Levine A.Transfusion-related acute lung injury in cardiac surgery. Asian Cardiovasc. Thorac. Ann. 2006; 14 (3): 65—67.
42. БунятянА. А., ТрековаН. А.(ред.) Руководство по кардиоанестези-ологии. М.: Медицинское информационное агентство; 2005.
43. Рябов Г. А.Синдромы критических состояний. М.: Медицина; 1994.
44. Малышев В. Д., Андрюхин И. М., Бакушин B. C. и соавт.Гемогидродина-мический мониторинг при интенсивном лечении больных с тяжелым течением перитонита. Анестезиология и реаниматология 1997; 3: 68—71.
45. Гельфанд Б. Р., Проценко Д. Н., Игнатенко О. В. и соавт.Острое повреждение легких вследствие трансфузии препаратов крови. Вестн. службы крови России 2007; 2: 38—42.
46. Palfi M., Berg S., ErnerudhJ., Berlin G.A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001; 41 (3): 317—322.
47. Kopko P. M., Marshall C. S., MacKenzie M. R. et al.Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287 (15): 1968—1971.
48. Fontaine M. J., MaloneJ., Mullins F. M., Grumet F. C.Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI? Ann. Clin. Lab. Sci. 2006; 36 (1): 53—58.
49. Goodnough L. T.What is transfusion medicine specialist? Transfusion 1999; 39 (9): 1031 — 1033.
50. McCullough J.Research in transfusion medicine. Transfusion 2000; 40 (9): 1033—1035.
51. Popovsky M. A.Transfusion and lung injury. Transfus. Clin. Biol. 2001; 8 (3): 272—277.
52. РудновB. A., ЗубаревА. С., БазаровА. С. исоавт.Современная практика инфузионо-трансфузионной терапии в ОРИТ России. Вестн. службы крови России 2006; 2: 11—19.
53. Жибурт Е. Б., Шестаков Е. А.Доказательная трансфузиология. Часть 1. О правилах назначения компонентов крови. Здравоохранение 2007; 11: 31—37.
54. Неговский В. А., Мороз В. В.Актуальные вопросы реаниматологии. Анестезиология и реаниматология 1999; 1: 6—9.
Review
For citations:
Afonin A.N., Moroz V.V., Karpun N.A. Acute Transfusion-Associated Lung Injury . General Reanimatology. 2009;5(2):70. (In Russ.) https://doi.org/10.15360/1813-9779-2009-2-70
Views:
1696
Email this article 